Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
50.0%
% of PJP's 24 holdings also in IHE
35.3%
% of IHE's 34 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 6.7% | 26.1% | 6.7% | |
JOHNSON & JOHNSON | 5.7% | 23.4% | 5.7% | |
MERCK & CO. INC. | 6.0% | 4.7% | 4.7% | |
PFIZER INC | 5.2% | 4.3% | 4.3% | |
JAZZ PHARMACEUTICALS PLC | 3.3% | 3.4% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to IHE
AMGEN INC | 6.4% | |
GILEAD SCIENCES INC | 6.2% | |
ABBOTT LABORATORIES | 6.1% | |
ABBVIE INC | 5.9% | |
UNITED THERAPEUTICS CORP | 3.8% | |
TARO PHARMACEUTICAL INDUS | 3.8% | |
REGENERON PHARMACEUTICALS | 3.6% | |
BIOGEN IDEC INC | 3.3% | |
GERON CORP | 3.2% | |
VALEANT PHARMACEUTICALS INT'L | 3.1% |
PJP Underweight Relative to IHE
ELI LILLY & CO | -19.3% | |
JOHNSON & JOHNSON | -17.7% | |
ZOETIS INC | -4.7% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
VIATRIS, INC. | -4.5% | |
BRISTOL-MYERS SQUIBB CO | -4.1% | |
CATALENT INC | -3.1% | |
ELANCO ANIMAL HEALTH, INC. | -2.6% | |
INTRA-CELLULAR THERAPIES INC | -2.3% | |
ORGANON & CO. | -1.3% |